Egnyte Creates Egnyte for Life Sciences Platform
Egnyte has announced Egnyte for Life Sciences, a purpose-built platform to serve those advancing the science of health. Egnyte’s solution aims to help biotech, medical device, and diagnostics companies accomplish three outcomes: meeting regulatory compliance standards, expedite data sharing and collaboration, and secure essential intellectual property.
The platform provides document management capabilities to facilitate intra- and inter-institutional collaboration while maintaining compliance with FDA 21 CFR Part 11 directives.
Egnyte is also announcing the formation of a Life Sciences Advisory Board to shape its offerings and go-to-market strategy in the industry.
Read the full release, here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
